ClinicalTrials.Veeva

Menu

Vocal Biomarkers of Craving (IVOMOC)

U

University of Bordeaux

Status

Enrolling

Conditions

Addiction

Treatments

Other: Cue reactivity paradigm
Other: Ecological momentary assessment

Study type

Observational

Funder types

Other

Identifiers

NCT07878624
25.01781.000582
2025-A01101-48 (Other Grant/Funding Number)

Details and patient eligibility

About

Addiction is a psychiatric disorder associated with craving, an unwanted, intense and persistent desire to use the substance/addictive behavior, leading to frequent relapses. Craving is fluctuating, influenced by internal factors or environmental context, and can be evaluated only by self-report which can be burdensome. It has been shown that craving predicts relapse, making it a major treatment target in addiction. Identify biomarkers of craving could enable to detect craving in a passive way (without major effort from individuals to report it) and would be a major improvement. The goal of this observational study is to explore if voice could be a biomarker of craving in adults with substance or behavioral addictions. The main question it aims to answer is:

• Is there voice features associated with craving episodes in addiction ? Participants will undergo a cue-reactivity protocol with different voice tasks, and then answer Ecological Momentary Assessment (EMA) questionnaires on smartphone, with some of the questionnaires recorded out loud with the smartphone's microphone.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Identify at least one main problematic substance (cannabis, tobacco, alcohol, opiates, stimulant) or one main problematic addictive behavior (e.g : video games, gambling, food, sex…) as the primary addiction
  • PresentDiagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) diagnosis for current Use Disorder for this primary addiction
  • Report regular craving and use of this primary addiction (more than 10 days in the last 30 days)
  • For participants recruited in treatment centers: receive outpatient treatment for this primary addiction

Trial design

120 participants in 1 patient group

Participants with DSM-5 diagnosis for a substance use disorder (SUD) or a behavioral addiction
Description:
Adults meeting Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) criteria for diagnosis for a substance use disorder (SUD) /behavioral addiction, recruited to complete voice recordings during cue-reactivity protocol and during 14-28 days Ecological Momentary Assessment (EMA) protocol.
Treatment:
Other: Ecological momentary assessment
Other: Cue reactivity paradigm

Trial contacts and locations

1

Loading...

Central trial contact

Fuschia SERRE, Ph-D; Fuschia SERRE, Ph-D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems